Patients Stopping Weight-Loss Injections Regain Pounds Four Times Faster Compared to Dieters

New research reveals that people who stop using blockbuster slimming jabs like Wegovy and Mounjaro may regain reduced body mass at a significantly accelerated pace than those who end traditional lifestyle regimens.

Findings released in a prominent medical journal points out that while overweight individuals can lose about a fifth of their body weight while on the medication, the weight comes back at an average rate of nearly a kilo each month once they quit.

"People buying these treatments should be aware of the risk of fast rebound weight gain when the medication concludes," warns expert Dr. Susan Jebb.

Such speed of regain suggests a reversion to pre-treatment weight within about 18 months.

Analyzing Approaches

The analysis, which reviewed 37 of studies involving thousands of patients, compared the results of these new drugs with other pills.

The team note that people who shed pounds through diet and exercise generally experience a less rapid creep back—around 100 grams monthly—post-intervention.

Understanding the Rapid Rebound

Doctors propose the way of the jabs accounts for the accelerated rebound.

GLP-1 drugs mimic a natural hormone called GLP-1, which moderates feelings of fullness.

"Artificially providing GLP-1 concentrations far above than normal may cause the system to produce less of its endogenous hormone, and could lessen responsiveness to its actions," noted Dr. Adam Collins, a nutrition specialist.

"Withdrawal of this GLP-1 'fix' means hunger is unsuppressed, making excessive eating far more likely."

A Lifelong Disease?

Health authorities advise the jabs for individuals with weight-linked health risks, accompanied by recommended lifestyle changes.

Professionals contend that, considering the likelihood of weight regain, the therapy should be considered ongoing.

This opinion is reinforced by drug manufacturers, who note that the results "emphasize the chronic character of obesity," comparing it to managing conditions like diabetes.

Patient Testimonies

Users who have stopped the jabs report a powerful resurgence of appetite.

"It was like something activating and you're instantly ravenous," recalled a patient.

This challenge is worsened if individuals have not developed lasting dietary or behavioural modifications during therapy.

Significant Adoption

Figures indicate that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with interest being substantial.

• Adoption is greater among women compared to males.
• The middle-aged age group shows the highest usage rates.
• Many access the medications through private prescriptions rather than public health services.

In conclusion, researchers stress that while the jabs are effective tools for weight loss, they are not a magic cure and long-term success relies on integrated lifestyle management.